Thyroid Advocate Mary Shomon Features Amerithroid™ in Her Newsletter
RIDGEWOOD, NJ — JULY 17, 2026 — Amerithroid™ (Thyroid Tablets, USP) was featured in Sticking Out Our Necks — Hormonal Health News with Mary Shomon, the newsletter of thyroid patient advocate and author Mary Shomon, in an article published on July 16, 2026, titled “Why Amerithroid Makes Me Optimistic About the Future of Natural Desiccated Thyroid.”
In the piece, Shomon shares her optimism about the launch of Amerithroid as a new American-made natural desiccated thyroid (NDT) medication. She frames it as meaningful for patients who prefer NDT options and who have faced concerns about supply shortages and regulatory uncertainty, emphasizing that Amerithroid represents an expansion of treatment choices rather than a replacement for existing therapies.
The article specifically welcomes the involvement of domestic manufacturers in thyroid care, noting that “the team of Jerome Stevens and Oliva Therapeutics is investing in U.S.-based production.”
Shomon is a patient advocate who has connected with tens of thousands of people with hypothyroidism over three decades and has personally taken NDT medication for more than 20 years, advocating for individualized thyroid treatment options.
Read the full article:
https://hormones.substack.com/p/why-amerithroid-makes-me-optimistic
More information on Amerithroid can be found at www.amerithroid.com.
